Keen R W, Nguyen T, Sobnack R, Perry L A, Thompson P W, Spector T D
Rheumatology Department, St. Thomas' Hospital, London, UK.
Osteoporos Int. 1996;6(5):399-406. doi: 10.1007/BF01623014.
A number of recent studies have suggested that non-invasive measures of bone turnover are associated with bone loss at the forearm in postmenopausal women. Whether bone turnover markers are predictive of bone loss from the clinically important sites of lumbar spine and femoral neck remain unclear, and was the aim of this 4-year prospective study. One hundred and forty-one normal, postmenopausal women (mean age 52.0 +/- 3.3 years, mean menopause duration 20.4 +/- 5.7 months) were recruited for the study in 1988. Fasting early morning samples of blood and urine were collected at the baseline visit and stored at -20 degrees C prior to analysis. Serum was assayed for osteocalcin, oestradiol, oestrone, oestrone sulphate, testosterone, sex hormone binding globulin, dehydroepiandrosterone sulphate and total alkaline phosphatase. Urine was assayed for calcium, hydroxyproline, oestrone glucuronide and the collagen cross-links pyridinoline and deoxypyridinoline using high-performance liquid chromatography. Bone density was measured at the lumbar spine and femoral neck using dual photon absorptiometry at time 0, 12, 24 and 48 months. The mean annual percentage change in bone density (SE) was -1.41% (0.18) at the lumbar spine and -0.86% (0.22) at the femoral neck. There was no evidence of bimodality or a fast loser subgroup as the rates of change were normally distributed. Both simple and multiple stepwise regression analyses revealed no significant correlation between the rates of change in bone density with any biochemical marker, either individually or in combination, despite the study having sufficient power (80%) to detect a correlation of 0.5 between any biochemical marker levels and bone loss. We conclude that single measurements of these markers of bone turnover and endogenous sex hormones appear unlikely to be clinically useful in predicting early postmenopausal bone loss from either the spine or the hip.
最近的一些研究表明,绝经后女性前臂骨量流失与骨转换的非侵入性测量指标有关。骨转换标志物是否能预测腰椎和股骨颈这些临床重要部位的骨量流失仍不清楚,而这正是这项为期4年的前瞻性研究的目的。1988年招募了141名正常的绝经后女性(平均年龄52.0±3.3岁,平均绝经时间20.4±5.7个月)参与该研究。在基线访视时采集空腹晨尿和血样,分析前储存在-20℃。检测血清中的骨钙素、雌二醇、雌酮、硫酸雌酮、睾酮、性激素结合球蛋白、硫酸脱氢表雄酮和总碱性磷酸酶。使用高效液相色谱法检测尿液中的钙、羟脯氨酸、葡萄糖醛酸雌酮以及胶原交联物吡啶啉和脱氧吡啶啉。在第0、12、24和48个月时,使用双能光子吸收法测量腰椎和股骨颈的骨密度。腰椎骨密度的年平均变化率(标准误)为-1.41%(0.18),股骨颈为-0.86%(0.22)。由于变化率呈正态分布,没有证据表明存在双峰现象或快速骨量流失亚组。尽管该研究有足够的检验效能(80%)来检测任何生化标志物水平与骨量流失之间0.5的相关性,但单因素和多因素逐步回归分析均显示,骨密度变化率与任何生化标志物(单独或联合)之间均无显著相关性。我们得出结论,这些骨转换标志物和内源性性激素的单次测量似乎不太可能在临床上用于预测绝经后早期脊柱或髋部的骨量流失。